Intellia CRISPR gene editing data puts heat on Alnylam; shares down 5%
June 28 2021 - 12:42PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Mar 2023 to Mar 2024